Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:selecta_biosciences [2023/02/04 07:08]
liam [Organization]
+++ pharmaceutical_companies:selecta_biosciences [2024/03/26 20:00] (current)
liam
@@ Line 24: / Line 24: @@
   * [[Swedish Orphan Biovitrum]] (Sobi)
   * [[Takeda]]
+==== Patents ====
+^ Number  ^ Title  ^ Date filed  ^ Inventor(s)  ^
+| [[https://web.archive.org/web/20230204063213/https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2012149411|WO2012149411]]  | CONTROLLED RELEASE OF IMMUNOSUPPRESSANTS FROM SYNTHETIC NANOCARRIERS  | April 27, 2012  | [[:David Altreuter]], [[Aaron Griset]], [[Roberto Maldonaldo]]  |
 ===== Organization =====
@@ Line 36: / Line 41: @@
 | [[:Blaine Davis]]  | Chief Financial Officer  | [[Protera Therapeutics]], [[Insmed]], [[Endo International]], [[:Endo Ventures]], [[Bristol-Myers Squibb]]  |
 | [[:Matthew Bartholomae]]  | General Counsel, Secretary  | [[Minerva Neurosciences]]  |
+| [[:Ann Donohue]]  | Vice President of Finance & Controller  | -  |
+| [[:Ulrich von Andrian]]  | Co-Founder and Co-Chair of the Scientific Advisory Board  | -  |
 | [[:Carrie Cox]]  | Chairman  | [[Humacyte]], [[Schering-Plough]], [[Pharmacia & Upjohn]], [[:Texas Instruments]], [[:Cardinal Health]], [[Organon]], [[Celgene]], [[Array BioPharma]], [[medical_technology_companies:electroCore]], [[Prism Pharmaceutical]]  |
 | [[:Timothy Barabe]]  | Director  | [[ArQule]], [[:Veeva Systems]], [[Vigilant Biosciences]], [[medical_technology_companies:Affymetrix]], [[Human Genome Sciences]], [[:Regent Medical]], [[Sandoz]]  |
@@ Line 75: / Line 82: @@
   * [[https://www.linkedin.com/company/selecta-bio/|LinkedIn]]
   * [[https://twitter.com/selectabio|Twitter]]
+  * [[https://wiki.whiteroseintelligence.com/en/Selecta-Biosciences|White Rose Wiki]]